Firdausi Qadri | |
---|---|
ফিরদৌসী কাদরী | |
Born | 31 March 1951 |
Nationality | Bangladeshi |
Alma mater | |
Awards | full list |
Scientific career | |
Fields | Immunology, vaccine, microbiology |
Institutions | ICDDR,B |
Firdausi Qadri (born 31 March 1951) is a Bangladeshi scientist with specialization in immunology and infectious disease research. She has worked over 25 years on the development of vaccines for cholera [1] and has expertise on other infectious disease like ETEC, Typhoid, Helicobacter pylori , rotavirus, etc. Currently, she is working as a director for Centre for Vaccine Sciences of International Centre for Diarrhoeal Disease and Research, Bangladesh (ICDDR,B). She also serves as chairperson of the Institute for developing Science and Health initiatives. [2] Her scientific achievements lie in enteric infections and vaccines including Vibrio cholerae and enterotoxigenic Escherichia coli—major causes of severe diarrhea. She has also focused on studying the immune response in Helicobacter pylori infected people in Bangladesh and the responses in patients with typhoid fever as well as vaccinees. [1] The Government of Bangladesh awarded her the Independence Award in 2023. [3]
This section of a biography of a living person does not include any references or sources .(January 2021) |
Qadri got her BSc and MSc degree in biochemistry and molecular biology from the University of Dhaka in 1975 and 1977 respectively. In 1980, she got her PhD degree in biochemistry/immunology from University of Liverpool. After completing her postdoc in immunology from ICDDR,B she joined as an associate scientist in 1988 in the same institution. Currently, she is the senior scientist and director of Centre for Vaccine Science at ICDDR,B.
Qadri has focused her research on enteric diseases, specifically in the areas of immunology, genomics, proteomic technology and diagnostics, and vaccine development. She endeavored to introduce a new cheap oral cholera vaccine in Bangladesh [4] in replacement of Dukoral, which is costly for poor people and cost-ineffective as a public health tool. [5] She demonstrated the efficacy of Shanchol vaccine in mass population in slam areas in Dhaka, [6] then worked to have it adopted as a public health intervention in Bangladesh, [7] including Rohingya refugees. [8]
In 2012, Qadri was awarded the Fondation Christophe et Rodolphe Mérieux's annual scientific 'Grand Prize', called the "Christophe Mérieux Prize", for her research on infectious enteric diseases. [9] [10] This award made possible the creation of the Institute for Developing Science and Health Initiatives (ideSHi) in 2014. [11] In 2014, she has been named as a member of a high-level panel which will advise the UN chief on the organizational and operational aspects of a proposed Technology Bank and Science, Technology and Innovation Supporting Mechanism dedicated to the least developed countries. [12] She is also listed in the top 100 Asian Scientists list. This list is published by Asian Scientist Magazine. [13]
In August 2021, the Ramon Magsaysay Award was presented to Firdausi Qadri. [14]
Qadri is a founder and a member of Board of Advisory of the Bangladesh Society of Microbiologists. [15] She is the International Ambassador for the American Society for Microbiology Bangladesh [16] and a fellow of the Bangladesh Academy of Sciences since 2008. [17]
Bacteriology is the branch and specialty of biology that studies the morphology, ecology, genetics and biochemistry of bacteria as well as many other aspects related to them. This subdivision of microbiology involves the identification, classification, and characterization of bacterial species. Because of the similarity of thinking and working with microorganisms other than bacteria, such as protozoa, fungi, and viruses, there has been a tendency for the field of bacteriology to extend as microbiology. The terms were formerly often used interchangeably. However, bacteriology can be classified as a distinct science.
Rita Rossi Colwell is an American environmental microbiologist and scientific administrator. Colwell holds degrees in bacteriology, genetics, and oceanography and studies infectious diseases. Colwell is the founder and Chair of CosmosID, a bioinformatics company. From 1998 to 2004, she was the 11th Director and 1st female Director of the National Science Foundation. She has served on the board of directors of EcoHealth Alliance since 2012.
Gopinath Balakrish Nair is an Indian microbiologist known for his work on cholera. At present, he is the Ag. Regional Adviser, Research Policy and Cooperation Unit, Department of Communicable Diseases, World Health Organization. Before joining WHO, he was the executive director of Translational Health Science and Technology Institute (THSTI), Faridabad, NCR, India. Before joining THSTI, he was working in NICED as the director. He has also served as the director of Laboratory Sciences Division at the International Center for Diarrhoeal Diseases Research,, Dhaka, Bangladesh.
Stanley Alan Plotkin is an American physician who works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. In the 1960s, he played a pivotal role in discovery of a vaccine against rubella virus while working at Wistar Institute in Philadelphia. Plotkin was a member of Wistar’s active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, he is emeritus professor of Pediatrics at the University of Pennsylvania. His book, Vaccines, is the standard reference on the subject. He is an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C.
ICDDR,B is an international health research organisation located in Dhaka, Bangladesh. Dedicated to saving lives through research and treatment, ICDDR,B addresses some of the most critical health concerns facing the world today, ranging from improving neonatal survival to HIV/AIDS. In collaboration with academic and research institutions worldwide, ICDDR,B conducts research, training and extension activities, as well as programme-based initiatives, to develop and share knowledge for global lifesaving solutions.
Dilip Mahalanabis was an Indian paediatrician known for pioneering the use of oral rehydration therapy to treat diarrhoeal diseases. Mahalanabis had begun researching oral rehydration therapy in 1966 as a research investigator for the Johns Hopkins University International Center for Medical Research and Training in Calcutta, India. During the Bangladeshi war for independence, he led the effort by the Johns Hopkins Center that demonstrated the dramatic life-saving effectiveness of oral rehydration therapy when cholera broke out in 1971 among refugees from East Bengal who had sought asylum in West Bengal. The simple, inexpensive Oral Rehydration Solution (ORS) gained acceptance, and was later hailed as one of the most important medical advances of the 20th century.
A cholera vaccine is a vaccine that is effective at reducing the risk of contracting cholera. The recommended cholera vaccines are administered orally to elicit local immune responses in the gut where the intestinal cells produce antibodies against the cholera microbe. This immune response was poorly achieved with the injectable vaccines that were used until the 1970s. The first effective oral cholera vaccine was Dukoral, developed in Sweden in the 1980s. For the first six months after vaccination it provides about 85% protection, which decreases to approximately 60% during the first two years. When enough of the population is immunized, it may protect those who have not been immunized thereby increasing the total protective impact to more than 90 %.
Richard Alan Cash was an American global health researcher, public health physician, and internist. He was a pioneer of oral rehydration therapy for lethal diseases such as cholera. This simple, practical therapy is estimated to have saved over 50 million lives since.
Shah Mohammad Faruque is a professor and the dean of the School of Environment and Life Sciences at Independent University Bangladesh (IUB). He is widely recognized for his research in Vibrio cholerae, the bacterium which causes the epidemic diarrhoeal disease Cholera. Among other positions, previously he was a professor at BRAC University; director of the Genomics Centre at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), and formerly director of the Centre for Food and Water Borne Diseases in ICDDR,B. His areas of research interest include microbial genomics, bacteriophages, environmental microbiology, ecology, and evolution of bacterial pathogens, particularly those associated with waterborne and foodborne diseases. Faruque is primarily known for his work in genomics, epidemiology and ecology of the cholera pathogen, and its bacteriophages.
Matlab was an upazila of the Chandpur District of the Chittagong Division, Bangladesh. In 2000, the administrative area was subdivided into Matlab Dakshin Upazila and Matlab Uttar Upazila.
Edward Thomas Ryan is an American microbiologist, immunologist, and physician at Harvard University and Massachusetts General Hospital. Ryan served as president of the American Society of Tropical Medicine and Hygiene from 2009 to 2010. Ryan is Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, Professor of Medicine at Harvard Medical School, and Director of Global Infectious Diseases at the Massachusetts General Hospital. Ryan's research and clinical focus has been on infectious diseases associated with residing in, immigrating from, or traveling through resource-limited areas. Ryan is a Fellow of the American Society of Microbiology, the American Society of Tropical Medicine and Hygiene, the American College of Physicians, and the Infectious Diseases Society of America.
Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19, and long COVID.
Bangladesh Academy of Sciences (BAS) is an academic forum for Bangladeshi scientists and technologists. Established in 1973, it aims to fulfill the role of promoting research and development of sciences in Bangladesh.
Francine NtoumiPh.D., HDR, PvDz, FRCPedin is a Congolese parasitologist specializing in malaria. She was the first African person in charge of the secretariat of the Multilateral Initiative on Malaria (2006-2010). In recent years, she has become involved in research on other infectious diseases, including COVID-19.
Samir Kumar Saha is an eminent Bangladeshi microbiologist and public health expert. He is the professor, senior consultant and head of the department of Diagnostic Division of Microbiology at the Dhaka Shishu Hospital for children and also the executive director of The Child Health Research Foundation (CHRF) at the Bangladesh Institute of Child Health.
Jean-Jacques Muyembe is a Congolese microbiologist. He is the general director of the Democratic Republic of the Congo Institut National pour la Recherche Biomedicale (INRB). He was part of team at the Yambuku Catholic Mission Hospital that investigated the first Ebola outbreak, and was part of the effort that discovered Ebola as a new disease, although his exact role is still subject to controversy. In 2016, he led the research that designed, along with other researchers at the INRB and the National Institute of Health Vaccine Research Center in the US, one of the most promising treatment for Ebola, mAb114. The treatment was successfully tested during recent outbreaks in the DRC, on the express decision of the then DRC Minister of Health, Dr Oly Ilunga, despite advice against this from the World Health Organization.
Roger I. Glass is an American physician-scientist who served as the Director of the John E. Fogarty International Center.
Wiley Henry Mosley is an epidemiologist and international public health professional. He is Emeritus Professor in the Department of Population, Family and Reproductive Health at Johns Hopkins Bloomberg School of Public Health.
2021 (MMXXI) was a common year starting on Friday of the Gregorian calendar, the 2021st year of the Common Era (CE) and Anno Domini (AD) designations, the 21st year of the 3rd millennium and the 21st century, and the 2nd year of the 2020s decade.
Jan Roland Holmgren is a Swedish physician, microbiologist, immunologist, and vaccinologist, known for his research on cholera and mucosal immunology, specifically, for his leadership in developing "the world's first effective oral cholera vaccine".